Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2012; 18(24): 3156-3166
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3156
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3156
Included studies | Country | Study period | Sample size | Comparison | Measured outcomes |
Bansal et al[5], 2010 | India | 2007-2008 | 30 | Preoperative ERCP/EST + LC (n = 15) vs LC + LCBDE (n = 15) | Successful removal of gallbladder and CBD clearance, complications |
Rogers et al[24], 2010 | United States | 1997-2003 | 122 | Preoperative ERCP/EST + LC (n = 61) vs LC + LCBDE (n = 61) | Stone clearance from CBD, length of hospital stay, cost of index hospitalization, hospital charges, professional fees, patient acceptance, morbidity, mortality, quality of life scores |
Rhodes et al[25], 1998 | United Kingdom | 1995-1997 | 80 | Postoperative ERCP/EST + LC (n = 40) vs LC + LCBDE (n = 40) | Duct-clearance rates, morbidity, operating time and hospital stay |
Cuschieri et al[26], 1999 | Scotland | 1994-1997 | 300 | Preoperative ERCP/EST + LC (n = 150) vs LC + LCBDE (n = 150) | Hospital stay, success rates, conversion rates, morbidity and mortality |
Nathanson et al[27], 2005 | Australia | 1998-2003 | 86 | Postoperative ERCP/EST + LC (n = 45) vs LC + LCBDE (n = 41) | Operative time, morbidity, retained stone rate, reoperation rate and hospital stay |
Sgourakis et al[28], 2002 | Greece | 1997-2000 | 78 | Preoperative ERCP/EST + LC (n = 42) vs LC + LCBDE (n = 36) | Stone clearance, morbidity, mortality, conversion, hospital stay, complications |
Noble et al[29], 2009 | United Kingdom | 2000-2006 | 91 | Preoperative ERCP/EST + LC (n = 47) vs LC + LCBDE (n = 44) | Duct clearance, complications, number of procedures per patient, conversion and hospital stay |
Included studies | Stone clearance from the CBD (%) | Postoperative morbidity (%) | Mortality (%) | Conversion to other procedures (%) | Number of procedures per patient | Length of hospital stay (d) | Total operating time (min) (SD or range) | Hospitalization charges ($) (SD or range) |
Bansal et al[5], 2010 | 86.7 vs 93.3 | Not mentioned | 0 vs 0 | 15.4 vs 6.7 | Not mentioned | 4 (2-11) vs 4.2 (3-9) | 153 (120-240) vs ? | Not mentioned |
Rogers et al[24], 2010 | 96.8 vs 88.2 | 9.1 vs 10.5 | 0 vs 0 | 1.8 vs 3.5 | 2.0 vs 1.0 | 4.1 (3.5) vs 2.3 (1.9) | 183 (39) vs 174 (67) | 30 617 (16 384) vs 27 675 (11 256) |
Rhodes et al[25], 1998 | 75 vs 75 | 15 vs 17.5 | Not mentioned | 0 vs 25 | 2.4 vs 1.3 | 3.5 (1-11) vs 1 (1-26) | 105 (60-255) vs 90 (25-310) | Not mentioned |
Cuschieri et al[26], 1999 | 83.7 vs 82.6 | 12.5 vs 15.8 | 1.5 vs 0.8 | 14.7 vs 15 | 2.0 vs 1.2 | 9 (5.5-14) vs 6 (4.2-12) | Not mentioned | Not mentioned |
Nathanson et al[27], 2005 | 71.1 vs 97.6 | 13.3 vs 17.1 | 0 vs 0 | 6.7 vs 4.9 | 2.3 vs 1.2 | 7.7 vs 6.4 | 147.9 vs 158.8 | Not mentioned |
Sgourakis et al[28], 2002 | 84.3 vs 85.7 | 18.8 vs 17.9 | 3.1 vs 0 | 15.6 vs 14.3 | 2.1 vs 1.1 | 9 vs 7.4 | 105 (60-255) vs 90 (70-310) | Not mentioned |
Noble et al[29], 2009 | 55.6 vs 100 | 29.8 vs 43.2 | Not mentioned | 42.6 vs 9.1 | 2.3 vs 1.0 | 3 (2-7) vs 5 (2-7) | Not mentioned | Not mentioned |
Included studies | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
Bansal et al[5], 2010 | Low risk | Low risk | High risk | Unclear risk | High risk | High risk | Unclear risk |
Rogers et al[24], 2010 | Low risk | Low risk | High risk | Unclear risk | High risk | Low risk | Low risk |
Rhodes et al[25], 1998 | Unclear risk | Unclear risk | High risk | Unclear risk | Low risk | High risk | Unclear risk |
Cuschieri et al[26], 1999 | Low risk | Unclear risk | High risk | Unclear risk | Low risk | High risk | Unclear risk |
Nathanson et al[27], 2005 | Low risk | Low risk | High risk | Unclear risk | Low risk | High risk | Unclear risk |
Sgourakis et al[28], 2002 | High risk | Unclear risk | High risk | Unclear risk | High risk | High risk | Low risk |
Noble et al[29], 2009 | Low risk | Unclear risk | High risk | Unclear risk | Low risk | High risk | Low risk |
-
Citation: Lu J, Cheng Y, Xiong XZ, Lin YX, Wu SJ, Cheng NS. Two-stage
vs single-stage management for concomitant gallstones and common bile duct stones. World J Gastroenterol 2012; 18(24): 3156-3166 - URL: https://www.wjgnet.com/1007-9327/full/v18/i24/3156.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i24.3156